Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124929882 | 12492988 | 2 | F | 201511 | 20160715 | 20160623 | 20160722 | EXP | JP-DSJP-DSJ-2016-114269 | DAIICHI | 0.00 | Y | 0.00000 | 20160722 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124929882 | 12492988 | 1 | PS | LIXIANA TABLETS | EDOXABAN TOSILATE MONOHYDRATE | 1 | Oral | 30 MG, QD | Y | 206316 | 30 | MG | TABLET | QD | |||||
| 124929882 | 12492988 | 2 | SS | LOXONIN | LOXOPROFEN SODIUM | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
| 124929882 | 12492988 | 3 | SS | CELECOX | CELECOXIB | 1 | Unknown | UNK | 0 | ||||||||||
| 124929882 | 12492988 | 4 | SS | MEIACT | CEFDITOREN PIVOXIL | 1 | Unknown | UNK | 0 | ||||||||||
| 124929882 | 12492988 | 5 | C | ARTIST TABLETS 2.5mg | 2 | Oral | 2.5 MG, QD | 0 | 2.5 | MG | TABLET | QD | |||||||
| 124929882 | 12492988 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 124929882 | 12492988 | 7 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 124929882 | 12492988 | 8 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 124929882 | 12492988 | 9 | C | ADALAT | NIFEDIPINE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 124929882 | 12492988 | 10 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 124929882 | 12492988 | 11 | C | SIGMART | NICORANDIL | 1 | Oral | 5 MG, TID | 0 | 5 | MG | TID | |||||||
| 124929882 | 12492988 | 12 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 250 MG, 6 TMS EVERY 1D | 0 | 250 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124929882 | 12492988 | 1 | Deep vein thrombosis |
| 124929882 | 12492988 | 2 | Product used for unknown indication |
| 124929882 | 12492988 | 5 | Myocardial ischaemia |
| 124929882 | 12492988 | 6 | Dyslipidaemia |
| 124929882 | 12492988 | 7 | Gastritis prophylaxis |
| 124929882 | 12492988 | 8 | Myocardial ischaemia |
| 124929882 | 12492988 | 9 | Myocardial ischaemia |
| 124929882 | 12492988 | 10 | Hyperuricaemia |
| 124929882 | 12492988 | 11 | Myocardial ischaemia |
| 124929882 | 12492988 | 12 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124929882 | 12492988 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124929882 | 12492988 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124929882 | 12492988 | 1 | 20150508 | 20160420 | 0 |